uridine diphosphate n-acetylgalactosamine and Brain Neoplasms

uridine diphosphate n-acetylgalactosamine has been researched along with Brain Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arvanitis, TN; Griffin, JL; Kauppinen, RA; McConville, C; Mirbahai, L; Pan, X; Peet, AC; Wilson, M1

Other Studies

1 other study(ies) available for uridine diphosphate n-acetylgalactosamine and Brain Neoplasms

ArticleYear
In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells.
    Journal of proteome research, 2011, Aug-05, Volume: 10, Issue:8

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cisplatin; Humans; Magnetic Resonance Spectroscopy; Metabolomics; Monitoring, Physiologic; Prognosis; Rats; Uridine Diphosphate N-Acetylgalactosamine; Uridine Diphosphate N-Acetylglucosamine

2011